• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    Philip Morris International Reports 2024 Second-Quarter and First-Half Results and Raises Full Year Guidance

    7/23/24 6:59:00 AM ET
    $PM
    Medicinal Chemicals and Botanical Products
    Health Care
    Get the next $PM alert in real time by email

    Second-Quarter Reported Diluted EPS grew 52.5% to $1.54

    Adjusted Diluted EPS decreased by 0.6% to $1.59; and grew by 10.6% excluding currency

    Regulatory News:

    Philip Morris International Inc. (PMI) (NYSE:PM) today announces its 2024 second-quarter and first-half results.1

    "The excellent momentum of our smoke-free business continued with an outstanding second-quarter and first-half performance," said Jacek Olczak, Chief Executive Officer.

    "The powerful combination of excellent underlying performance and proactive measures across all categories enabled our business to outperform once again, and we are on track for a strong 2024. As a result, we are raising our full-year guidance, despite currency headwinds."

    Second Quarter Highlights

    • Smoke-free business (SFB): The smoke-free business accounted for 38.1% of our total net revenues (up by 2.7pp versus second-quarter last year), with 36.5 million estimated adult users of our smoke-free products (up by 3.2 million versus December 2023), which are available in 90 markets. Our SFB continues to deliver superior performance, with net revenues increasing by 13.6% (18.3% organically) and gross profit increasing by 15.6% (22.2% organically).
    • Inhalable smoke-free products (SFP): Total IQOS users at quarter-end were estimated at 30.8 million (up by 1.9 million versus December 2023), of which approximately 22.1 million had fully switched to IQOS and stopped smoking. The increase was broad-based, with notable gains in Japan following the launch of ILUMA i, as well as good progress in Europe (especially Greece, Hungary, Romania, Bulgaria, and Spain), South Korea, and low and middle income markets, notably Indonesia. Market share for HTUs in IQOS markets was up by 0.7pp to 8.1%. HTU adjusted in-market sales (IMS) volume, which excludes the net impact of estimated distributor and wholesaler inventory movements was up by an estimated 10.2%, in line with expectations.
      • In Japan, IQOS HTU market share increased by more than 3 percentage points to over 29%, and offtake share exceeded 30% for the first time in June. TEREA and SENTIA were the #1 and #3 nicotine brands respectively in the quarter. Adjusted IMS grew by 12.5%, the 7th consecutive quarter of double-digit growth.
      • In Europe, IQOS HTU adjusted market share increased by 0.8pp to 9.8% with adjusted IMS growth of 6.8%, which, as expected, was impacted by the EU characterizing flavor ban, especially in Italy.

    In the vaping category, our focused strategy is showing promising early results, with VEEV taking the #1 position in the closed pod segment in 5 European markets within 12 months of launch.

    • Oral SFP2: Shipment volume increased by 23.5% in cans (20.0% in pouches or pouch equivalents), fueled by ZYN nicotine pouch growth in the U.S., where shipments reached 135.1 million cans, representing growth of 50.3% versus prior year. ZYN, despite supply constraints, performed in-line with the U.S. nicotine pouch category in terms of consumer offtake. Outside of the U.S., our nicotine pouch volume grew by over 50% with promising results in a number of new markets, notably Pakistan.
    • Combustibles: Net revenues grew by 1.2% (organically by 4.8%), driven by another quarter of high single-digit pricing and resilient industry volumes. After 7 consecutive quarters of gross margin contraction, profitability recovered in Q2 with very robust expansion of 40 bps (50 bps on an organic basis), primarily driven by pricing.
    • Dividend: We declared a regular quarterly dividend of $1.30 per share, or an annualized $5.20 per share.

    __________________________

    1 Explanation of PMI's use of non-GAAP measures cited in this document and reconciliations to the most directly comparable U.S. GAAP measures can be found in the "Non-GAAP Measures, Glossary and Explanatory Notes" section of this release, in Exhibit 99.2 to the company's Form 8-K dated July 23, 2024, and at www.pmi.com/2024Q2earnings.

    2 Oral smoke-free products volume excludes snuff, snuff leaf and U.S. chew

    Operating Review - Second Quarter

     

     

    Total

     

    HTU

     

    Oral SFP3

     

    Cigarettes

     

     

     

     

     

     

     

     

     

    Shipment Volume (units bn)

     

    197.3

     

    35.5

     

    4.2

     

    157.6

    vs. Q2 2023

     

    2.8%

     

    13.1%

     

    20.0%

     

    0.4%

     

     

    PMI

     

    Smoke-Free

    Business

     

    Combustibles

     

     

     

     

     

     

     

     

     

    Net Revenues ($ bn)

     

    $9.5

     

    $3.6

     

    $5.9

     

    reported vs. Q2 2023

     

    5.6%

     

    13.6%

     

    1.2%

     

    organic vs. Q2 2023

     

    9.6%

     

    18.3%

     

    4.8%

     

     

     

     

     

     

     

     

     

    Gross Profit ($ bn)

     

    $6.1

     

    $2.3

     

    $3.8

     

    reported vs. Q2 2023

     

    6.7%

     

    15.6%

     

    1.8%

     

    organic vs. Q2 2023

     

    11.5%

     

    22.2%

     

    5.5%

     

     

     

     

     

     

     

     

     

    Operating Income ($ bn)

     

    $3.4

     

     

     

     

     

    reported vs. Q2 2023

     

    34.2%

     

     

     

     

     

    organic vs. Q2 2023

     

    12.5%

     

     

     

     

     

     

     

    Reported

    Diluted

    EPS

     

    Adjusting

    Items*

     

    Adjusted

    Diluted

    EPS

     

    Currency

    Impact

     

    Adjusted

    Diluted

    EPS ex. Currency

     

     

     

     

     

     

     

     

     

     

     

    EPS

     

    $1.54

     

    $(0.05)

     

    $1.59

     

    $(0.18)

     

    $1.77

    vs. Q2 2023

     

    52.5%

     

     

     

    (0.6)%

     

     

     

    10.6%

    (*) For a list of adjusting items refer to page 19

    __________________________

    3 In pouches or pouch equivalents

    Full-Year Forecast

     

     

    Full-Year

     

     

    2024

    Forecast

     

    2023

     

    Growth

     

     

     

     

     

     

     

     

     

     

     

    Reported Diluted EPS

     

    $5.89

    -

    $6.01

     

    $ 5.02

     

     

     

     

    Adjustments:

     

     

     

     

     

     

     

     

     

     

    Asset impairment and exit costs

     

    0.09

     

    0.06

     

     

     

     

    Termination of distribution arrangement in the Middle East

     

    —

     

    0.04

     

     

     

     

    Impairment of goodwill and other intangibles

     

    0.01

     

    0.44

     

     

     

     

    Amortization of intangibles(1)

     

    0.43

     

    0.25

     

     

     

     

    Charges related to the war in Ukraine

     

    —

     

    0.03

     

     

     

     

    Swedish Match AB acquisition accounting related items

     

    —

     

    0.01

     

     

     

     

    Income tax impact associated with Swedish Match AB financing

     

    0.09

     

    (0.11)

     

     

     

     

    South Korea indirect tax charge

     

    —

     

    0.11

     

     

     

     

    Termination of agreement with Foundation for a Smoke-Free World

     

    —

     

    0.07

     

     

     

     

    Fair value adjustment for equity security investments

     

    (0.15)

     

    (0.02)

     

     

     

     

    Tax items

     

    (0.03)

     

    0.11

     

     

     

     

    Total Adjustments

     

    0.44

     

    0.99

     

     

     

     

    Adjusted Diluted EPS

     

    $6.33

    -

    $6.45

     

    $ 6.01

     

    5.3%

    -

    7.3%

    Less: Currency

     

    (0.34)

     

     

     

     

     

     

    Adjusted Diluted EPS, excluding currency

     

    $6.67

    -

    $6.79

     

    $ 6.01

     

    11.0%

    -

    13.0%

    (1) See forecast assumptions for details

    Reported diluted EPS is forecast to be in a range of $5.89 to $6.01, at prevailing exchange rates, versus reported diluted EPS of $5.02 in 2023. Excluding a total 2024 adjustment of $0.44 per share, this forecast represents a projected increase of 5.3% to 7.3% versus adjusted diluted EPS of $ 6.01 in 2023. Also excluding an adverse currency impact of $0.34, at prevailing exchange rates, this forecast represents a projected increase of 11.0% to 13.0% versus adjusted diluted EPS of $6.01 in 2023, as outlined in the above table.

    2024 Full-Year Forecast Assumptions

    This forecast assumes:

    • A broadly stable total international industry volume for cigarettes and HTUs, excluding China and the U.S.;
    • Total cigarette, HTU and oral smoke-free product shipment volume growth for PMI of 1% to 2% driven by smoke-free products;
    • A second half acceleration in HTU adjusted IMS to deliver around 13% growth for the full year, and HTU shipment volumes of around 140 billion units. This assumes no volumes in Taiwan and a slightly greater impact from consumer adjustment to the EU characterizing flavor ban than previously assumed;
    • Nicotine pouch shipment volume in the U.S. of 560 to 580 million cans;
    • Net revenue growth of 7.5% to 9% on an organic basis;
    • Organic operating income growth of 11% to 13%;
    • An acceleration in organic smoke-free net revenue and gross profit growth compared to 2023;
    • Broadly unchanged net revenue and adjusted operating loss in Wellness and Healthcare segment compared to 2023;
    • No earnings impact from the May 15, 2024 Fiscal Court in Dusseldorf ruling related to the legality of a supplemental tax surcharge on HTUs in Germany, which went into effect in 2022. On June 19, 2024, a German subsidiary of PMI submitted an appeal;
    • Full-year amortization of acquired intangibles of $0.43 per share, which includes an estimate of amortization of IQOS commercialization rights in the U.S. following the closing of the agreement to end our commercial relationship with Altria Group, Inc. covering IQOS in the U.S. effective May 1, 2024;
    • Net financing costs of approximately $1.3 billion;
    • An effective tax rate, excluding discrete tax events, of approximately 21% to 22%;
    • Operating cash flow of approximately $11 billion at prevailing exchange rates, subject to year-end working capital requirements;
    • Capital expenditures of approximately $1.3 to $1.4 billion, including further investments in ZYN capacity in the U.S.;
    • Net debt to adjusted EBITDA ratio improvement of 0.3x to 0.5x at prevailing exchange rates as we continue to target a ratio of around 2x by the end of 2026;
    • No share repurchases in 2024; and
    • A strong second-half performance, with third quarter adjusted diluted EPS of $1.77 to $1.82 including an estimated adverse currency impact of 2 cents at prevailing exchange rates.

    Factors described in the Forward-Looking and Cautionary Statements section of this release represent continuing risks to these projections.

    Conference Call

    A conference call hosted by Emmanuel Babeau, Chief Financial Officer, will be webcast at 9:00 a.m., Eastern Time, on July 23, 2024. Access the webcast at www.pmi.com/2024Q2earnings.

    Financial Review

    TOTAL MARKET, CONSOLIDATED SHIPMENT VOLUME & MARKET SHARE

    Total Market Volume

    Second-Quarter

    Estimated international industry volume (excluding China and the U.S.) for cigarettes and HTUs increased by 1.5%, reflecting increases in the SSEA, CIS & MEA Region, partly offset by decreases in the Europe, Americas and EA, AU & PMI DF Regions, as described in the Regional sections below.

    Six Months Year-to-Date

    Estimated international industry volume (excluding China and the U.S.) for cigarettes and HTUs increased by 1.1%, reflecting increase in the SSEA, CIS & MEA Region, partly offset by decreases in the Europe and Americas Regions, and broadly stable in the EA, AU & PMI DF Region, as described in the Regional sections below.

    Consolidated Shipment Volume

    PMI Cigarettes and HTUs

     

    Second-Quarter

     

    Six Months Year-to-Date

    (million units)

     

    2024

     

    2023

     

    Change

     

    2024

     

    2023

     

    Change

    Cigarettes

     

    157,618

     

    157,010

     

    0.4%

     

    300,809

     

    300,718

     

    —%

    Heated Tobacco Units

     

    35,544

     

    31,424

     

    13.1%

     

    68,678

     

    58,820

     

    16.8%

    Total Cigarettes and HTUs

     

    193,162

     

    188,434

     

    2.5%

     

    369,487

     

    359,538

     

    2.8%

    PMI Oral SFP(1)

     

    Second-Quarter

     

    Six Months Year-to-Date

    (million cans)

     

    2024

     

    2023

     

    Change

     

    2024

     

    2023

     

    Change

    Nicotine Pouches

     

    149.9

     

    99.5

     

    50.6%

     

    295.6

     

    180.7

     

    63.5%

    Snus

     

    58.8

     

    62.6

     

    (6.2)%

     

    120.2

     

    118.2

     

    1.7%

    Moist Snuff

     

    34.2

     

    34.1

     

    0.2%

     

    68.6

     

    69.3

     

    (1.1)%

    Other Oral SFP(2)

     

    1.0

     

    1.2

     

    (17.0)%

     

    2.0

     

    2.5

     

    (16.8)%

    Total Oral SFP

     

    243.8

     

    197.4

     

    23.5%

     

    486.4

     

    370.7

     

    31.2%

    (1) Excluding snuff, snuff leaf and U.S. chew

    (2) Includes chew bags and tobacco bits

    Note: Sum may not foot due to roundings.

    Second-Quarter

    PMI's total cigarette and HTU shipment volume increased by 2.5% (HTU shipments increased by 13.1%, and cigarette shipments increased by 0.4%), with increases across all regions except the Americas.

    PMI's total oral product shipment volume in cans increased by 23.5%, predominantly reflecting growth in nicotine pouches.

    Adjusted in-market sales for HTUs increased by 10.2%, including growth in Japan of 12.5% and Europe of 6.8%.

    Six Months Year-to-Date

    PMI's total cigarette and HTU shipment volume increased by 2.8% (HTU shipments increased by 16.8%, while cigarette shipments were stable).

    PMI's total oral product shipment volume in cans increased by 31.2%, primarily reflecting growth in nicotine pouches.

    Adjusted in-market sales for HTUs increased by 11.4%, including growth in Japan of 12.9% and Europe of 8.0%. A net favorable impact of estimated distributor inventory movements for HTU shipments was driven most significantly by additional shipments to Japan in light of disruption to Red Sea shipping routes.

    International Share of Market - Cigarettes and HTUs

     

     

    Second-Quarter

     

    Six Months Year-to-Date

     

    2024

     

    2023

     

    Change

    (pp)

     

    2024

     

    2023

     

    Change

    (pp)

     

     

     

     

     

     

     

     

     

     

     

     

     

    Total International Market Share(1)

     

    28.7%

     

    28.6%

     

    0.1

     

    28.3%

     

    27.9%

     

    0.4

    Cigarettes

     

    23.6%

     

    24.0%

     

    (0.4)

     

    23.2%

     

    23.4%

     

    (0.2)

    HTU

     

    5.1%

     

    4.7%

     

    0.4

     

    5.1%

     

    4.6%

     

    0.5

     

     

     

     

     

     

     

     

     

     

     

     

     

    Cigarette over Cigarette Market Share(2)

     

    25.3%

     

    25.5%

     

    (0.2)

     

    24.9%

     

    24.9%

     

    —

    (1) Defined as PMI's cigarette and heated tobacco unit in-market sales volume as a percentage of total industry cigarette and heated tobacco unit sales volume, excluding China and the U.S., including cigarillos in Japan

    (2) Defined as PMI's cigarette in-market sales volume as a percentage of total industry cigarette sales volume, excluding China and the U.S., including cigarillos in Japan

    Note: Sum of share of market by product categories might not foot to total due to roundings.

    CONSOLIDATED FINANCIAL SUMMARY

    Second-Quarter

    Financial Summary -

    Quarters Ended
    June 30,

     

     

     

     

     

    Change

    Fav./(Unfav.)

     

    Variance

    Fav./(Unfav.)

     

    2024

     

    2023

     

    Total

     

    Excl.

    Curr. &

    Acquis.

     

    Total

     

    Cur-

    rency

     

    Acqui-

    sitions

     

    Price

     

    Vol/

    Mix

     

    Cost/

    Other

    (in millions)

     

     

     

     

     

     

     

     

     

     

    Net Revenues

     

    $

    9,468

     

     

    $

    8,967

     

     

    5.6

    %

     

    9.6

    %

     

    501

     

     

    (358

    )

     

    —

     

    583

     

    303

     

     

    (27

    )

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Cost of Sales(1)

     

     

    (3,345

    )

     

     

    (3,228

    )

     

    (3.6

    )%

     

    (5.9

    )%

     

    (117

    )

     

    63

     

     

    12

     

    —

     

    (145

    )

     

    (47

    )

    Marketing, Administration and Research Costs(2)

     

     

    (2,679

    )

     

     

    (2,508

    )

     

    (6.8

    )%

     

    (5.4

    )%

     

    (171

    )

     

    (36

    )

     

    —

     

    —

     

    —

     

     

    (135

    )

    Impairment of Goodwill

     

     

    —

     

     

     

    (665

    )

     

    +100%

     

    +100

    %

     

    665

     

     

    —

     

     

    —

     

    —

     

    —

     

     

    665

     

    Operating Income

     

    $

    3,444

     

     

    $

    2,566

     

     

    34.2

    %

     

    46.6

    %

     

    878

     

     

    (331

    )

     

    12

     

    583

     

    158

     

     

    456

     

    Impairment of Goodwill and Other Intangibles (3)

     

     

    —

     

     

     

    (680

    )

     

    +100%

     

    +100

    %

     

    680

     

     

    —

     

     

    —

     

    —

     

    —

     

     

    680

     

    Amortization of Intangibles

     

     

    (212

    )

     

     

    (82

    )

     

    -(100

    )%

     

    -(100

    )%

     

    (130

    )

     

    —

     

     

    —

     

    —

     

    —

     

     

    (130

    )

    South Korea Indirect Tax Charge

     

     

    —

     

     

     

    (204

    )

     

    +100%

     

    +100

    %

     

    204

     

     

    —

     

     

    —

     

    —

     

    —

     

     

    204

     

    Adjusted Operating Income

     

    $

    3,656

     

     

    $

    3,532

     

     

    3.5

    %

     

    12.5

    %

     

    124

     

     

    (331

    )

     

    12

     

    583

     

    158

     

     

    (298

    )

    Adjusted Operating Income Margin

     

     

    38.6

    %

     

     

    39.4

    %

     

    (0.8

    )pp

     

    1.1

    pp

     

     

     

     

     

     

     

     

     

     

     

     

    (1) Includes $16 million in 2024 and $22 million in 2023 related to the special items below.

    (2) Includes $196 million in 2024 and $279 million in 2023 related to the special items below.

    (3) Includes $665 million impairment of goodwill in 2023

    Net revenues increased by 9.6% on an organic basis, mainly reflecting: a favorable pricing variance, primarily due to higher combustible tobacco pricing; and favorable volume/mix, driven by higher smoke-free products volume.

    Adjusted operating income increased by 12.5% on an organic basis, mainly reflecting: the favorable pricing variance; and favorable volume/mix, mainly driven by smoke-free products volume, notwithstanding unfavorable cigarette mix; partly offset by higher costs, predominantly marketing, administration and research costs.

    Six Months Year-to-Date

    Financial Summary -

    Six Months Ended June 30,

     

     

     

     

     

    Change

    Fav./(Unfav.)

     

    Variance

    Fav./(Unfav.)

     

    2024

     

    2023

     

    Total

     

    Excl.

    Curr. &

    Acquis

     

    Total

     

    Cur-

    rency

     

    Acqui-

    sitions

     

    Price

     

    Vol/

    Mix

     

    Cost/

    Other

    (in millions)

     

     

     

     

     

     

     

     

     

     

    Net Revenues

     

    $

    18,261

     

     

    $

    16,986

     

     

    7.5

    %

     

    10.8

    %

     

    1,275

     

     

    (552

    )

     

    —

     

    1,032

     

    767

     

     

    28

     

    Termination of distribution arrangement in the Middle East

     

     

    —

     

     

     

    (80

    )

     

    +100

    %

     

    +100

    %

     

    80

     

     

    —

     

     

    —

     

    —

     

    —

     

     

    80

     

    Adjusted Net Revenues

     

    $

    18,261

     

     

    $

    17,066

     

     

    7.0

    %

     

    10.2

    %

     

    1,195

     

     

    (552

    )

     

    —

     

    1,032

     

    767

     

     

    (52

    )

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Net Revenues

     

    $

    18,261

     

     

    $

    16,986

     

     

    7.5

    %

     

    10.8

    %

     

    1,275

     

     

    (552

    )

     

    —

     

    1,032

     

    767

     

     

    28

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Cost of Sales (1)

     

     

    (6,540

    )

     

     

    (6,266

    )

     

    (4.4

    )%

     

    (5.7

    )%

     

    (274

    )

     

    71

     

     

    12

     

    —

     

    (314

    )

     

    (43

    )

    Marketing, Administration and Research Costs (2)

     

     

    (5,232

    )

     

     

    (4,758

    )

     

    (10.0

    )%

     

    (6.2

    )%

     

    (474

    )

     

    (178

    )

     

    —

     

    —

     

    —

     

     

    (296

    )

    Impairment of Goodwill

     

     

    —

     

     

     

    (665

    )

     

    +100

    %

     

    +100

    %

     

    665

     

     

    —

     

     

    —

     

    —

     

    —

     

     

    665

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Operating Income

     

    $

    6,489

     

     

    $

    5,297

     

     

    22.5

    %

     

    34.7

    %

     

    1,192

     

     

    (659

    )

     

    12

     

    1,032

     

    453

     

     

    354

     

    Asset Impairment & Exit Costs

     

     

    (168

    )

     

     

    (109

    )

     

    (54.1

    )%

     

    (54.1

    )%

     

    (59

    )

     

    —

     

     

    —

     

    —

     

    —

     

     

    (59

    )

    Termination of distribution arrangement in the Middle East (3)

     

     

    —

     

     

     

    (80

    )

     

    +100

    %

     

    +100

    %

     

    80

     

     

    —

     

     

    —

     

    —

     

    —

     

     

    80

     

    Impairment of Goodwill and Other Intangibles (4)

     

     

    (27

    )

     

     

    (680

    )

     

    96.0

    %

     

    96.0

    %

     

    653

     

     

    —

     

     

    —

     

    —

     

    —

     

     

    653

     

    Amortization of Intangibles

     

     

    (332

    )

     

     

    (163

    )

     

    -(100

    )%

     

    -(100

    )%

     

    (169

    )

     

    —

     

     

    —

     

    —

     

    —

     

     

    (169

    )

    Swedish Match AB acquisition accounting related items

     

     

    —

     

     

     

    (18

    )

     

    +100

    %

     

    +100

    %

     

    18

     

     

    —

     

     

    —

     

    —

     

    —

     

     

    18

     

    South Korea Indirect Tax Charge

     

     

    —

     

     

     

    (204

    )

     

    +100

    %

     

    +100

    %

     

    204

     

     

    —

     

     

    —

     

    —

     

    —

     

     

    204

     

    Adjusted Operating Income

     

    $

    7,016

     

     

    $

    6,551

     

     

    7.1

    %

     

    17.0

    %

     

    465

     

     

    (659

    )

     

    12

     

    1,032

     

    453

     

     

    (373

    )

    Adjusted Operating Income Margin

     

     

    38.4

    %

     

     

    38.4

    %

     

    —

    pp

     

    2.3

    pp

     

     

     

     

     

     

     

     

     

     

     

     

    (1) Includes $32 million in 2024 and $62 million in 2023 related to the special items below.

    (2) Includes $495 million in 2024 and $447 million in 2023 related to the special items below.

    (3) Included in Net Revenues above.

    (4) Includes $665 million impairment of goodwill in 2023.

    Adjusted net revenues increased by 10.2% on an organic basis, mainly reflecting: a favorable pricing variance, primarily driven by higher combustible tobacco pricing; and favorable volume/mix, driven by higher smoke-free products volume, partly offset by unfavorable cigarette mix.

    Adjusted operating income increased by 17.0% on an organic basis, mainly reflecting: the favorable pricing variance, predominantly driven by higher combustible tobacco pricing; and favorable volume/mix, mainly driven by higher smoke-free products volume; partly offset by higher marketing, administration and research costs (primarily due to inflationary impacts, notably related to wages, and higher commercial investments), as well as higher manufacturing costs (primarily due to inflationary impacts, notably related to tobacco leaf and the impact of the EU single-use plastics directive, partly offset by productivity).

    EUROPE REGION

    Total Market, PMI Shipment & Market Share Commentaries

    Second-Quarter

    The estimated total market for cigarettes and HTUs in the Region decreased by 1.7% to 138.0 billion units, reflecting a 2.8% decline for cigarettes, partly offset by an increase for HTUs. The decrease in the estimated total market was predominantly due to France (down by 11.4%), the UK (down by 15.4%), Germany (down by 3.3%), and the Netherlands (down by 20.7%), partly offset by Bulgaria (up by 10.6%), Romania (up by 5.0%), and Greece (up by 8.3%).

    Six Months Year-to-Date

    The estimated total market for cigarettes and HTUs in the Region decreased by 1.2% to 262.1 billion units, reflecting a 2.6% decline for cigarettes, partly offset by an increase for HTUs. The decrease in the estimated total market was predominantly due to France (down by 13.8%), the UK (down by 13.3%), and the Netherlands (down by 15.5%), partly offset by Bulgaria (up by 9.7%), Poland (up by 2.3%), Romania (up by 3.9%), and Greece (up by 7.1%).

    Europe Key Data

     

    Second-Quarter

     

    Six Months Year-to-Date

     

     

     

     

     

     

    Change

     

     

     

     

     

    Change

     

     

    2024

     

    2023

     

    % / pp

     

    2024

     

    2023

     

    % / pp

    PMI Shipment Volume (million units)

     

     

     

     

     

     

     

     

     

     

     

     

    Cigarettes

     

    43,467

     

    43,741

     

    (0.6)%

     

    80,556

     

    82,898

     

    (2.8)%

    Heated Tobacco Units

     

    12,935

     

    11,705

     

    10.5%

     

    24,275

     

    21,804

     

    11.3%

    Total Europe

     

    56,402

     

    55,446

     

    1.7%

     

    104,831

     

    104,702

     

    0.1%

     

     

     

     

     

     

     

     

     

     

     

     

     

    PMI Market Share

     

     

     

     

     

     

     

     

     

     

     

     

    Cigarettes

     

    30.2%

     

    30.3%

     

    (0.1)

     

    30.1%

     

    30.3%

     

    (0.2)

    Heated Tobacco Units

     

    9.6%

     

    8.8%

     

    0.8

     

    9.8%

     

    8.9%

     

    0.9

    Total Europe

     

    39.8%

     

    39.1%

     

    0.7

     

    40.0%

     

    39.2%

     

    0.8

    Note: Sum may not foot due to roundings.

    Europe Oral SFP

     

    Second-Quarter

     

    Six Months Year-to-Date

     

     

    2024

     

    2023

     

    Change

     

    2024

     

    2023

     

    Change

    PMI Shipment Volume (million cans)

     

     

     

     

     

     

     

     

     

     

     

     

    Nicotine Pouches

     

    11.8

     

    9.3

     

    26.9%

     

    24.1

     

    17.2

     

    40.2%

    Snus

     

    58.0

     

    61.4

     

    (5.6)%

     

    118.7

     

    115.8

     

    2.5%

    Other Oral SFP(1)

     

    1.0

     

    1.2

     

    (17.0)%

     

    2.0

     

    2.5

     

    (16.8)%

    Total Europe

     

    70.8

     

    71.9

     

    (1.6)%

     

    144.8

     

    135.4

     

    6.9%

    (1) Includes chew bags and tobacco bits

    Note: Sum may not foot due to roundings.

    Second-Quarter

    PMI's total cigarette and HTU shipment volume in the Region increased by 1.7% to 56.4 billion units. Total cigarette and HTU shipment volume increased notably in Italy (up by 7.6%), mainly driven by cigarettes, and Poland (up by 6.0%), and decreased notably in France (down by 11.7%) and the Netherlands (down by 19.5%), both driven by cigarettes.

    PMI's estimated HTU adjusted in-market sales volume in the Region increased by 6.8% in the quarter, reflecting continued growth momentum for IQOS, partly offset by the impact from the EU characterizing flavor ban.

    PMI's HTU share of the total cigarette and HTU market in the Region increased by 0.8 points on an adjusted basis.

    Oral SFP shipments decreased by 1.6% with decline of snus (down by 5.6%), partly offset by nicotine pouches (up by 26.9%).

    Six Months Year-to-Date

    PMI's total cigarette and HTU shipment volume in the Region increased by 0.1% to 104.8 billion units. Total cigarette and HTU shipment volume increased notably in Poland (up by 7.9%), Greece (up by 9.6%), and Germany (up by 1.9%), and decreased notably in France (down by 21.7%) and the Netherlands (down by 15.2%), both driven by cigarettes.

    PMI's estimated HTU adjusted in-market sales volume in the Region increased by 8.0%, reflecting continued growth momentum for IQOS, partly offset by the impact from the EU characterizing flavor ban.

    PMI's HTU share of the total cigarette and HTU market in the Region increased by 0.9 points on an adjusted basis.

    Oral SFP shipments increased by 6.9%, driven by growth of nicotine pouches (up by 40.2%) and snus (up by 2.5%).

    Financial Summary

    Second-Quarter

    Financial Summary -

    Quarters Ended
    June 30,

     

     

     

     

     

    Change

    Fav./(Unfav.)

     

    Variance

    Fav./(Unfav.)

     

    2024

     

    2023

     

    Total

     

    Excl.

    Curr. &

    Acquis.

     

    Total

     

    Cur-

    rency

     

    Acqui-

    sitions

     

    Price

     

    Vol/

    Mix

     

    Cost/

    Other

    (in millions)

     

     

     

     

     

     

     

     

     

     

    Net Revenues

     

    $

    3,815

     

     

    $

    3,574

     

     

    6.7

    %

     

    7.0

    %

     

    241

     

     

    (9

    )

     

    —

     

    205

     

    45

     

    —

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Operating Income

     

    $

    1,660

     

     

    $

    1,619

     

     

    2.5

    %

     

    5.3

    %

     

    41

     

     

    (45

    )

     

    —

     

    205

     

    2

     

    (121

    )

    Adjustments (1)

     

     

    (40

    )

     

     

    (28

    )

     

    (41.8

    )%

     

    (41.8

    )%

     

    (12

    )

     

    —

     

     

    —

     

    —

     

    —

     

    (12

    )

    Adjusted Operating Income

     

    $

    1,701

     

     

    $

    1,647

     

     

    3.3

    %

     

    6.0

    %

     

    54

     

     

    (45

    )

     

    —

     

    205

     

    2

     

    (109

    )

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Adjusted Operating Income Margin

     

     

    44.6

    %

     

     

    46.1

    %

     

    (1.5

    )pp

     

    (0.4

    )pp

     

     

     

     

     

     

     

     

     

     

     

     

    (1) See Schedule 10 in Exhibit 99.2 to the Form 8-K dated July 23, 2024, for additional detail.

    Net revenues increased by 7.0% on an organic basis, reflecting: a favorable pricing variance, mainly driven by higher combustible tobacco pricing; and favorable volume/mix, primarily driven by higher HTU volume, partly offset by lower cigarettes volume.

    Adjusted operating income increased by 6.0% on an organic basis, reflecting: a favorable pricing variance, mainly driven by higher combustible tobacco pricing; partly offset by higher marketing, administration and research costs as well as manufacturing costs, including the impact of the EU single-use plastics directive.

    Six Months Year-to-Date

    Financial Summary -

    Six Months Ended June 30,

     

     

     

     

     

    Change

    Fav./(Unfav.)

     

    Variance

    Fav./(Unfav.)

     

    2024

     

    2023

     

    Total

     

    Excl.

    Curr. &

    Acquis.

     

    Total

     

    Cur-

    rency

     

    Acqui-

    sitions

     

    Price

     

    Vol/

    Mix

     

    Cost/

    Other

    (in millions)

     

     

     

     

     

     

     

     

     

     

    Net Revenues

     

    $

    7,180

     

     

    $

    6,642

     

     

    8.1

    %

     

    7.1

    %

     

    538

     

    69

     

     

    —

     

    368

     

    101

     

    —

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Operating Income

     

    $

    3,116

     

     

    $

    2,834

     

     

    10.0

    %

     

    11.0

    %

     

    282

     

    (31

    )

     

    —

     

    368

     

    66

     

    (121

    )

    Adjustments (1)

     

     

    (80

    )

     

     

    (103

    )

     

    22.0

    %

     

    22.0

    %

     

    23

     

    —

     

     

    —

     

    —

     

    —

     

    23

     

    Adjusted Operating Income

     

    $

    3,197

     

     

    $

    2,937

     

     

    8.9

    %

     

    9.9

    %

     

    260

     

    (31

    )

     

    —

     

    368

     

    66

     

    (143

    )

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Adjusted Operating Income Margin

     

     

    44.5

    %

     

     

    44.2

    %

     

    0.3

    pp

     

    1.2

    pp

     

     

     

     

     

     

     

     

     

     

     

     

    (1) See Schedule 11 in Exhibit 99.2 to the Form 8-K dated July 23, 2024, for additional detail.

    Net revenues increased by 7.1% on an organic basis, primarily driven by the same factors as for the quarter.

    Adjusted operating income increased by 9.9% on an organic basis, reflecting: a favorable pricing variance, mainly driven by higher combustible tobacco pricing; and favorable volume/mix, primarily driven by higher HTU volume, notwithstanding lower cigarette volume; partly offset by higher marketing, administration and research costs as well as manufacturing costs, including the impact of the EU single-use plastics directive.

    SSEA, CIS & MEA REGION

    Total Market, PMI Shipment & Market Share Commentaries

    Second-Quarter

    The estimated total market for cigarettes and HTUs in the Region increased by 3.7% to 393.9 billion units. The increase in the estimated total market was mainly due to Russia (up by 6.2%), Pakistan (up by 42.4%), Egypt (up by 18.6%), Bangladesh (up by 8.5%), and Turkey (up by 4.1%), partly offset by Thailand (down by 19.5%) and Kazakhstan (down by 8.8%).

    Six Months Year-to-Date

    The estimated total market for cigarettes and HTUs in the Region increased by 2.5% to 767.0 billion units. The increase in the estimated total market was mainly due to Turkey (up by 10.3%), Russia (up by 5.3%), Indonesia (up by 3.1%), and Bangladesh (up by 6.5%), partly offset by Thailand (down by 14.1%) and Philippines (down by 7.9%).

    PMI Shipment Volume

     

    Second-Quarter

     

    Six Months Year-to-Date

    (million units)

     

    2024

     

    2023

     

    Change

     

    2024

     

    2023

     

    Change

    Cigarettes

     

    87,391

     

    84,415

     

    3.5%

     

    167,582

     

    160,946

     

    4.1%

    Heated Tobacco Units

     

    6,937

     

    5,853

     

    18.5%

     

    13,015

     

    11,300

     

    15.2%

    Total SSEA, CIS & MEA

     

    94,328

     

    90,268

     

    4.5%

     

    180,597

     

    172,246

     

    4.8%

    Second-Quarter

    PMI's total cigarette and HTU shipment volume in the Region increased by 4.5% to 94.3 billion units, mainly driven by Turkey (up by 9.7%) and Saudi Arabia (up by 68.9% due to inventory movements), partly offset by Indonesia (down by 6.4%), Thailand (down by 24.9%) and the Philippines (down by 9.7%). PMI's estimated HTU adjusted in-market sales volume increased by 11.4%, with 18.5% HTU shipment volume growth. HTU shipment growth in Russia primarily reflects timing and cross-border dynamics, with limited underlying growth.

    Six Months Year-to-Date

    PMI's total cigarette and HTU shipment volume in the Region increased by 4.8% to 180.6 billion units, mainly driven by Turkey (up by 16.0%), partly offset by the Philippines (down by 14.2%). PMI's estimated HTU adjusted in-market sales volume increased by 13.1%, with 15.2% HTU shipment volume growth.

    Financial Summary

    Second-Quarter

    Financial Summary -

    Quarters Ended
    June 30,

     

     

     

     

     

    Change

    Fav./(Unfav.)

     

    Variance

    Fav./(Unfav.)

     

    2024

     

    2023

     

    Total

     

    Excl.

    Curr. &

    Acquis.

     

    Total

     

    Cur-

    rency

     

    Acqui-

    sitions

     

    Price

     

    Vol/

    Mix

     

    Cost/

    Other

    (in millions)

     

     

     

     

     

     

     

     

     

     

    Net Revenues

     

    $

    2,771

     

     

    $

    2,668

     

     

    3.9

    %

     

    13.3

    %

     

    103

     

    (251

    )

     

    —

     

    229

     

    123

     

    2

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Operating Income

     

    $

    891

     

     

    $

    880

     

     

    1.3

    %

     

    26.0

    %

     

    11

     

    (230

    )

     

    12

     

    229

     

    50

     

    (50

    )

    Adjustments (1)

     

     

    (5

    )

     

     

    (5

    )

     

    6.8

    %

     

    6.8

    %

     

    —

     

    —

     

     

    —

     

    —

     

    —

     

    —

     

    Adjusted Operating Income

     

    $

    896

     

     

    $

    885

     

     

    1.2

    %

     

    25.9

    %

     

    11

     

    (230

    )

     

    12

     

    229

     

    50

     

    (50

    )

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Adjusted Operating Income Margin

     

     

    32.3

    %

     

     

    33.2

    %

     

    (0.9

    )pp

     

    3.7

    pp

     

     

     

     

     

     

     

     

     

     

     

     

    (1) See Schedule 10 in Exhibit 99.2 to the Form 8-K dated July 23, 2024, for additional detail.

    Net revenues increased by 13.3% on an organic basis, primarily reflecting: a favorable pricing variance, mainly driven by higher combustible tobacco pricing; and favorable volume/mix, driven by higher HTU and cigarettes volume, as well as favorable HTU and cigarette mix.

    Adjusted operating income increased by 25.9% on an organic basis, primarily reflecting: a favorable pricing variance, mainly driven by higher combustible tobacco pricing; and favorable volume/mix, driven by higher smoke-free products and cigarettes volume, notwithstanding unfavorable cigarette mix; partly offset by higher manufacturing costs (primarily due to higher cost of tobacco leaf).

    Six Months Year-to-Date

    Financial Summary -

    Six Months Ended June 30,

     

     

     

     

     

    Change

    Fav./(Unfav.)

     

    Variance

    Fav./(Unfav.)

     

    2024

     

    2023

     

    Total

     

    Excl.

    Curr. &

    Acquis.

     

    Total

     

    Cur-

    rency

     

    Acqui-

    sitions

     

    Price

     

    Vol/

    Mix

     

    Cost/

    Other

    (in millions)

     

     

     

     

     

     

     

     

     

     

    Net Revenues

     

    $

    5,429

     

     

    $

    5,145

     

     

    5.5

    %

     

    14.2

    %

     

    284

     

     

    (445

    )

     

    —

     

    384

     

    267

     

    78

     

    Adjustment (1)

     

     

    —

     

     

     

    (80

    )

     

    +100

    %

     

    +100

    %

     

    80

     

     

    —

     

     

    —

     

    —

     

    —

     

    80

     

    Adjusted Net Revenues

     

    $

    5,429

     

     

    $

    5,225

     

     

    3.9

    %

     

    12.4

    %

     

    204

     

     

    (445

    )

     

    —

     

    384

     

    267

     

    (2

    )

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Net Revenues

     

    $

    5,429

     

     

    $

    5,145

     

     

    5.5

    %

     

    14.2

    %

     

    284

     

     

    (445

    )

     

    —

     

    384

     

    267

     

    78

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Operating Income

     

    $

    1,663

     

     

    $

    1,614

     

     

    3.0

    %

     

    31.5

    %

     

    49

     

     

    (471

    )

     

    12

     

    384

     

    96

     

    28

     

    Adjustments (2)

     

     

    (10

    )

     

     

    (122

    )

     

    92.1

    %

     

    92.1

    %

     

    112

     

     

    —

     

     

    —

     

    —

     

    —

     

    112

     

    Adjusted Operating Income

     

    $

    1,673

     

     

    $

    1,736

     

     

    (3.6

    )%

     

    22.8

    %

     

    (63

    )

     

    (471

    )

     

    12

     

    384

     

    96

     

    (84

    )

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Adjusted Operating Income Margin

     

     

    30.8

    %

     

     

    33.2

    %

     

    (2.4

    )pp

     

    3.1

    pp

     

     

     

     

     

     

     

     

     

     

     

     

    (1) Termination of distribution arrangement in the Middle East.

    (2) See Schedule 11 in Exhibit 99.2 to the Form 8-K dated July 23, 2024, for additional detail.

    Adjusted net revenues increased by 12.4% on an organic basis, primarily reflecting: a favorable pricing variance, mainly driven by higher combustible tobacco pricing; and favorable volume/mix, driven by higher cigarette and HTU volume and favorable cigarettes mix.

    Adjusted operating income increased by 22.8% on an organic basis, primarily reflecting: a favorable pricing variance, mainly driven by higher combustible tobacco pricing; and favorable volume/mix, driven by higher cigarette and HTU volume, notwithstanding unfavorable cigarette mix; partly offset by higher manufacturing costs (primarily due to higher cost of tobacco leaf).

    EA, AU AND PMI DF REGION

    Total Market, PMI Shipment & Market Share Commentaries

    Second-Quarter

    The estimated total market for cigarettes and HTUs in the Region, excluding China, decreased by 0.7% to 80.2 billion units, with a decline in cigarettes, partly offset by HTU growth. The decrease in the estimated total market was mainly driven by Australia (down by 29.1%), South Korea (down by 1.9%), and Taiwan (down by 4.2%), partly offset by International Duty Free (up by 8.5%) and Japan (up by 0.9%).

    Six Months Year-to-Date

    The estimated total market for cigarettes and HTUs in the Region, excluding China, was stable at 156.0 billion units, with HTU growth partly offset by a decline in cigarettes. The increase in the estimated total market was mainly driven by International Duty Free (up by 12.4%) and Japan (up by 1.0%), partly offset by Australia (down by 29.4%).

    PMI Shipment Volume

     

    Second-Quarter

     

    Six Months Year-to-Date

    (million units)

     

    2024

     

    2023

     

    Change

     

    2024

     

    2023

     

    Change

    Cigarettes

     

    11,872

     

    13,351

     

    (11.1)%

     

    23,440

     

    26,461

     

    (11.4)%

    Heated Tobacco Units

     

    15,474

     

    13,714

     

    12.8%

     

    31,073

     

    25,462

     

    22.0%

    Total EA, AU & PMI DF

     

    27,346

     

    27,065

     

    1.0%

     

    54,513

     

    51,923

     

    5.0%

    Second-Quarter

    PMI's total cigarette and HTU shipment volume in the Region increased by 1.0% to 27.3 billion units, driven by Japan (up by 5.0%), partly offset by Australia (down by 28.5%).

    PMI's estimated HTU adjusted in-market sales volume in the Region increased by 13.3% in the quarter, including growth in Japan of 12.5%.

    Six Months Year-to-Date

    PMI's total cigarette and HTU shipment volume in the Region increased by 5.0% to 54.5 billion units, driven by Japan (up by 12.6%), partly offset by Australia (down by 27.2%).

    PMI's estimated HTU adjusted in-market sales volume in the Region increased by 14.1%, including growth in Japan of 12.9%.

    Financial Summary

    Second-Quarter

    Financial Summary -

    Quarters Ended
    June 30,

     

     

     

     

     

    Change

    Fav./(Unfav.)

     

    Variance

    Fav./(Unfav.)

     

    2024

     

    2023

     

    Total

     

    Excl.

    Curr. &

    Acquis.

     

    Total

     

    Cur-

    rency

     

    Acqui-

    sitions

     

    Price

     

    Vol/

    Mix

     

    Cost/

    Other

    (in millions)

     

     

     

     

     

     

     

     

     

     

    Net Revenues

     

    $

    1,673

     

     

    $

    1,680

     

     

    (0.4

    )%

     

    6.7

    %

     

    (7

    )

     

    (120

    )

     

    —

     

    88

     

    25

     

    —

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Operating Income

     

    $

    753

     

     

    $

    557

     

     

    35.2

    %

     

    51.5

    %

     

    196

     

     

    (91

    )

     

    —

     

    88

     

    2

     

    197

     

    Adjustments (1)

     

     

    (1

    )

     

     

    (205

    )

     

    99.7

    %

     

    99.7

    %

     

    204

     

     

    —

     

     

    —

     

    —

     

    —

     

    204

     

    Adjusted Operating Income

     

    $

    753

     

     

    $

    762

     

     

    (1.2

    )%

     

    10.8

    %

     

    (9

    )

     

    (91

    )

     

    —

     

    88

     

    2

     

    (7

    )

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Adjusted Operating Income Margin

     

     

    45.0

    %

     

     

    45.4

    %

     

    (0.4

    )pp

     

    1.7

    pp

     

     

     

     

     

     

     

     

     

     

     

     

    (1) See Schedule 10 in Exhibit 99.2 to the Form 8-K dated July 23, 2024, for additional detail.

    Net revenues increased by 6.7% on an organic basis, reflecting: a favorable pricing variance and favorable volume/mix, mainly driven by higher HTU volume, partly offset by lower cigarette volume.

    Adjusted operating income increased by 10.8% on an organic basis, primarily driven by the same factors as for net revenues.

    Six Months Year-to-Date

    Financial Summary -

    Six Months Ended June 30,

     

     

     

     

     

    Change

    Fav./(Unfav.)

     

    Variance

    Fav./(Unfav.)

     

    2024

     

    2023

     

    Total

     

    Excl.

    Curr. &

    Acquis.

     

    Total

     

    Cur-

    rency

     

    Acqui-

    sitions

     

    Price

     

    Vol/

    Mix

     

    Cost/

    Other

    (in millions)

     

     

     

     

     

     

     

     

     

     

    Net Revenues

     

    $

    3,357

     

     

    $

    3,200

     

     

    4.9

    %

     

    12.1

    %

     

    157

     

    (229

    )

     

    —

     

    218

     

    168

     

    —

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Operating Income

     

    $

    1,516

     

     

    $

    1,194

     

     

    27.0

    %

     

    45.1

    %

     

    322

     

    (216

    )

     

    —

     

    218

     

    74

     

    246

    Adjustments (1)

     

     

    (1

    )

     

     

    (225

    )

     

    99.3

    %

     

    99.3

    %

     

    224

     

    —

     

     

    —

     

    —

     

    —

     

    224

    Adjusted Operating Income

     

    $

    1,517

     

     

    $

    1,419

     

     

    6.9

    %

     

    22.1

    %

     

    98

     

    (216

    )

     

    —

     

    218

     

    74

     

    23

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Adjusted Operating Income Margin

     

     

    45.2

    %

     

     

    44.3

    %

     

    0.9

    pp

     

    4.0

    pp

     

     

     

     

     

     

     

     

     

     

     

     

    (1) See Schedule 11 in Exhibit 99.2 to the Form 8-K dated July 23, 2024, for additional detail.

    Net revenues increased by 12.1% on an organic basis, reflecting: a favorable pricing variance and favorable volume/mix, mainly driven by higher HTU volume, partly offset by lower cigarette volume.

    Adjusted operating income increased by 22.1% on an organic basis, primarily driven by the same factors as for net revenues.

    AMERICAS REGION

    Total Market, PMI Shipment & Market Share Commentaries

    Second-Quarter

    The estimated total market for cigarettes and HTUs in the Region, excluding the U.S., decreased by 2.7% to 45.2 billion units, primarily reflecting a decline for cigarettes. The decrease in the estimated total market was mainly due to Argentina (down by 20.0%) and Canada (down by 12.6%), partly offset by Brazil (up by 9.6%).

    Six Months Year-to-Date

    The estimated total market for cigarettes and HTUs in the Region, excluding the U.S., decreased by 2.8% to 89.9 billion units, primarily reflecting a decline for cigarettes. The decrease in the estimated total market was mainly due to Argentina (down by 13.8%) and Canada (down by 12.9%), partly offset by Brazil (up by 6.5%).

    PMI Shipment Volume

     

    Second-Quarter

     

    Six Months Year-to-Date

    (million units)

     

    2024

     

    2023

     

    Change

     

    2024

     

    2023

     

    Change

    Cigarettes

     

    14,888

     

    15,503

     

    (4.0)%

     

    29,231

     

    30,413

     

    (3.9)%

    Heated Tobacco Units

     

    198

     

    152

     

    30.3%

     

    315

     

    254

     

    24.0%

    Total Americas

     

    15,086

     

    15,655

     

    (3.6)%

     

    29,546

     

    30,667

     

    (3.7)%

    Note: Sum may not foot due to roundings.

    Americas Oral SFP1

     

    Second-Quarter

     

    Six Months Year-to-Date

     

     

    2024

     

    2023

     

    Change

     

    2024

     

    2023

     

    Change

    PMI Shipment Volume (million cans)

     

     

     

     

     

     

     

     

     

     

     

     

    Nicotine Pouches

     

    135.1

     

    89.9

     

    50.3%

     

    266.7

     

    163.1

     

    63.5%

    Moist Snuff

     

    34.2

     

    34.1

     

    0.2%

     

    68.6

     

    69.3

     

    (1.1)%

    Snus

     

    0.8

     

    1.2

     

    (37.3)%

     

    1.5

     

    2.4

     

    (38.4)%

    Total Americas

     

    170.1

     

    125.2

     

    35.8%

     

    336.7

     

    234.8

     

    43.4%

    (1) Excluding U.S. chew

    Note: Sum may not foot due to roundings.

    Second-Quarter

    PMI's total cigarette and HTU shipment volume in the Region decreased by 3.6% to 15.1 billion units, mainly due to Argentina (down by 19.9%), partly offset by Brazil (up by 8.7%).

    Oral products shipments increased by 35.8%, driven by ZYN nicotine pouches (up by 50.3%) in the U.S.

    Six Months Year-to-Date

    PMI's total cigarette and HTU shipment volume in the Region decreased by 3.7% to 29.5 billion units, mainly due to Argentina (down by 14.7%), partly offset by Brazil (up by 9.4%).

    Cigar shipment volume declined by 18.3%, predominantly due to a tough comparison related to trade inventory movements in the prior-year around the April 2023 price increase. Gross profit grew robustly.

    Oral products shipments increased by 43.4%, driven by ZYN nicotine pouches (up by 63.5%) in the U.S.

    Financial Summary

    Second-Quarter

    Financial Summary -

    Quarters Ended
    June 30,

     

     

     

     

     

    Change

    Fav./(Unfav.)

     

    Variance

    Fav./(Unfav.)

     

    2024

     

    2023

     

    Total

     

    Excl.

    Curr. &

    Acquis.

     

    Total

     

    Cur-

    rency

     

    Acqui-

    sitions

     

    Price

     

    Vol/

    Mix

     

    Cost/

    Other

    (in millions)

     

     

     

     

     

     

     

     

     

     

    Net Revenues

     

    $

    1,129

     

     

    $

    969

     

     

    16.5

    %

     

    14.2

    %

     

    160

     

     

    22

     

    —

     

    55

     

    110

     

    (27

    )

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Operating Income

     

    $

    183

     

     

    $

    243

     

     

    (24.7

    )%

     

    (39.1

    )%

     

    (60

    )

     

    35

     

    —

     

    55

     

    104

     

    (254

    )

    Adjustments (1)

     

     

    (152

    )

     

     

    (33

    )

     

    -(100

    )%

     

    -(100

    )%

     

    (119

    )

     

    —

     

    —

     

    —

     

    —

     

    (119

    )

    Adjusted Operating Income

     

    $

    335

     

     

    $

    276

     

     

    21.4

    %

     

    8.7

    %

     

    59

     

     

    35

     

    —

     

    55

     

    104

     

    (135

    )

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Adjusted Operating Income Margin

     

     

    29.7

    %

     

     

    28.5

    %

     

    1.2

    pp

     

    (1.4

    )pp

     

     

     

     

     

     

     

     

     

     

     

     

    (1) See Schedule 10 in Exhibit 99.2 to the Form 8-K dated July 23, 2024, for additional detail.

    Net revenues increased by 14.2% on an organic basis, primarily reflecting: favorable volume/mix, mainly due to the growth of ZYN nicotine pouches in the U.S., partly offset by lower cigarette volume and unfavorable cigarette mix outside of the U.S.; and favorable pricing variance, predominantly driven by higher combustible tobacco pricing.

    Adjusted operating income increased by 8.7% on an organic basis, mainly reflecting: favorable volume/mix and price variance, mainly due to the same factors as for net revenues; partly offset by higher marketing and administration costs, including incremental investment in the U.S.

    Six Months Year-to-Date

    Financial Summary -

    Six Months Ended June 30,

     

     

     

     

     

    Change

    Fav./(Unfav.)

     

    Variance

    Fav./(Unfav.)

     

    2024

     

    2023

     

    Total

     

    Excl.

    Curr. &

    Acquis.

     

    Total

     

    Cur-

    rency

     

    Acqui-

    sitions

     

    Price

     

    Vol/

    Mix

     

    Cost/

    Other

    (in millions)

     

     

     

     

     

     

     

     

     

     

    Net Revenues

     

    $

    2,125

     

     

    $

    1,837

     

     

    15.7

    %

     

    12.9

    %

     

    288

     

     

    51

     

    —

     

    54

     

    231

     

    (48

    )

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Operating Income

     

    $

    282

     

     

    $

    426

     

     

    (33.8

    )%

     

    (47.2

    )%

     

    (144

    )

     

    57

     

    —

     

    54

     

    217

     

    (472

    )

    Adjustments (1)

     

     

    (379

    )

     

     

    (95

    )

     

    -(100

    )%

     

    -(100

    )%

     

    (284

    )

     

    —

     

    —

     

    —

     

    —

     

    (284

    )

    Adjusted Operating Income

     

    $

    661

     

     

    $

    521

     

     

    26.9

    %

     

    15.9

    %

     

    140

     

     

    57

     

    —

     

    54

     

    217

     

    (188

    )

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Adjusted Operating Income Margin

     

     

    31.1

    %

     

     

    28.4

    %

     

    2.7

    pp

     

    0.7

    pp

     

     

     

     

     

     

     

     

     

     

     

     

    (1) See Schedule 11 in Exhibit 99.2 to the Form 8-K dated July 23, 2024, for additional detail.

    Net revenues increased by 12.9% on an organic basis, primarily reflecting: favorable volume/mix, mainly due to growth of ZYN nicotine pouches in the U.S., partly offset by cigarette volume declines outside of the U.S.; and favorable cigarette pricing.

    Adjusted operating income increased by 15.9% on an organic basis, mainly reflecting: favorable volume/mix, mainly due to the same factors as for net revenues; and favorable cigarette pricing; partly offset by higher marketing and administration costs, including incremental investment in the U.S.

    WELLNESS AND HEALTHCARE

    The results of PMI's Vectura Fertin Pharma business are reported in the Wellness and Healthcare segment.

    Second-Quarter

    Financial Summary -

    Quarters Ended
    June 30,

     

     

     

     

     

    Change

    Fav./(Unfav.)

     

    Variance

    Fav./(Unfav.)

     

    2024

     

    2023

     

    Total

     

    Excl.

    Curr. &

    Acquis.

     

    Total

     

    Cur-

    rency

     

    Acqui-

    sitions

     

    Price

     

    Vol/

    Mix

     

    Cost/

    Other

    (in millions)

     

     

     

     

     

     

     

     

     

     

    Net Revenues

     

    $

    80

     

     

    $

    76

     

     

    5.3

    %

     

    5.3

    %

     

    4

     

    —

     

    —

     

    6

     

    —

     

    (2

    )

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Operating Income / (Loss)

     

    $

    (43

    )

     

    $

    (733

    )

     

    94.1

    %

     

    94.1

    %

     

    690

     

    —

     

    —

     

    6

     

    —

     

    684

     

    Adjustments (1)

     

     

    (14

    )

     

     

    (695

    )

     

    97.9

    %

     

    97.9

    %

     

    681

     

    —

     

    —

     

    —

     

    —

     

    681

     

    Adjusted Operating Income / (Loss)

     

    $

    (29

    )

     

    $

    (38

    )

     

    23.7

    %

     

    23.7

    %

     

    9

     

    —

     

    —

     

    6

     

    —

     

    3

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Adjusted Operating Income / (Loss) Margin

     

     

    (36.3

    )%

     

     

    (50.0

    )%

     

    13.7

    pp

     

    13.7

    pp

     

     

     

     

     

     

     

     

     

     

     

     

    (1) See Schedule 10 in Exhibit 99.2 to the Form 8-K dated July 23, 2024, for additional detail.

    Net revenues increased by 5.3% on an organic basis. The adjusted operating loss of $29 million was primarily due to R&D and administration costs.

    Six Months Year-to-Date

    Financial Summary -

    Six Months Ended
    June 30,

     

     

     

     

     

    Change

    Fav./(Unfav.)

     

    Variance

    Fav./(Unfav.)

     

    2024

     

    2023

     

    Total

     

    Excl.

    Curr. &

    Acquis.

     

    Total

     

    Cur-

    rency

     

    Acqui-

    sitions

     

    Price

     

    Vol/

    Mix

     

    Cost/

    Other

    (in millions)

     

     

     

     

     

     

     

     

     

     

    Net Revenues

     

    $

    170

     

     

    $

    162

     

     

    4.9

    %

     

    3.7

    %

     

    8

     

    2

     

    —

     

    8

     

    —

     

    (2

    )

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Operating Income / (Loss)

     

    $

    (88

    )

     

    $

    (771

    )

     

    88.6

    %

     

    88.3

    %

     

    683

     

    2

     

    —

     

    8

     

    —

     

    673

     

    Adjustments (1)

     

     

    (56

    )

     

     

    (709

    )

     

    92.1

    %

     

    92.1

    %

     

    653

     

    —

     

    —

     

    —

     

    —

     

    653

     

    Adjusted Operating Income / (Loss)

     

    $

    (32

    )

     

    $

    (62

    )

     

    48.4

    %

     

    45.2

    %

     

    30

     

    2

     

    —

     

    8

     

    —

     

    20

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Adjusted Operating Income / (Loss) Margin

     

     

    (18.8

    )%

     

     

    (38.3

    )%

     

    19.5

    pp

     

    18.1

    pp

     

     

     

     

     

     

     

     

     

     

     

     

    (1) See Schedule 11 in Exhibit 99.2 to the Form 8-K dated July 23, 2024, for additional detail.

    Net revenues increased by 3.7% on an organic basis. The adjusted operating loss of $32 million was primarily due to R&D and administration costs.

    Philip Morris International: Delivering a Smoke-Free Future

    Philip Morris International (PMI) is a leading international tobacco company, actively delivering a smoke-free future and evolving its portfolio for the long term to include products outside of the tobacco and nicotine sector. The company's current product portfolio primarily consists of cigarettes and smoke-free products. Since 2008, PMI has invested over $12.5 billion to develop, scientifically substantiate and commercialize innovative smoke-free products for adults who would otherwise continue to smoke, with the goal of completely ending the sale of cigarettes. This includes the building of world-class scientific assessment capabilities, notably in the areas of pre-clinical systems toxicology, clinical and behavioral research, as well as post-market studies. In 2022, PMI acquired Swedish Match – a leader in oral nicotine delivery – creating a global smoke-free champion led by the companies' IQOS and ZYN brands. The U.S. Food and Drug Administration has authorized versions of PMI's IQOS devices and consumables and Swedish Match's General snus as Modified Risk Tobacco Products and renewal applications for these products are presently pending before the FDA. As of June 30, 2024, PMI's smoke-free products were available for sale in 90 markets, and PMI estimates that 36.5 million adults around the world use PMI's smoke-free products. Smoke-free business accounted for approximately 38% of PMI's total first-half 2024 net revenues. With a strong foundation and significant expertise in life sciences, PMI announced in February 2021 its ambition to expand into wellness and healthcare areas and, through its Vectura Fertin Pharma business, aims to enhance life through the delivery of seamless health experiences. For more information, please visit www.pmi.com and www.pmiscience.com.

    Forward-Looking and Cautionary Statements

    This press release contains projections of future results and goals and other forward-looking statements, including statements regarding expected financial or operational performance; capital allocation plans; investment strategies; regulatory outcomes; market expectations; and business plans and strategies. Achievement of future results is subject to risks, uncertainties and inaccurate assumptions. In the event that risks or uncertainties materialize, or underlying assumptions prove inaccurate, actual results could vary materially from those contained in such forward-looking statements. Pursuant to the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995, PMI is identifying important factors that, individually or in the aggregate, could cause actual results and outcomes to differ materially from those contained in any forward-looking statements made by PMI.

    PMI's business risks include: excise tax increases and discriminatory tax structures; increasing marketing and regulatory restrictions that could reduce our competitiveness, eliminate our ability to communicate with adult consumers, or ban certain of our products in certain markets or countries; health concerns relating to the use of tobacco and other nicotine-containing products and exposure to environmental tobacco smoke; litigation related to tobacco and/or nicotine use and intellectual property; intense competition; the effects of global and individual country economic, regulatory and political developments, natural disasters and conflicts; the impact and consequences of Russia's invasion of Ukraine; changes in adult smoker behavior; the impact of natural disasters and pandemics on PMI's business; lost revenues as a result of counterfeiting, contraband and cross-border purchases; governmental investigations; unfavorable currency exchange rates and currency devaluations, and limitations on the ability to repatriate funds; adverse changes in applicable corporate tax laws; adverse changes in the cost, availability, and quality of tobacco and other agricultural products and raw materials, as well as components and materials for our electronic devices; and the integrity of its information systems and effectiveness of its data privacy policies. PMI's future profitability may also be adversely affected should it be unsuccessful in its attempts to introduce, commercialize, and grow smoke-free products or if regulation or taxation do not differentiate between such products and cigarettes; if it is unable to successfully introduce new products, promote brand equity, enter new markets or improve its margins through increased prices and productivity gains; if it is unable to expand its brand portfolio internally or through acquisitions and the development of strategic business relationships; if it is unable to attract and retain the best global talent, including women or diverse candidates; or if it is unable to successfully integrate and realize the expected benefits from recent transactions and acquisitions. Future results are also subject to the lower predictability of our smoke-free products performance.

    PMI is further subject to other risks detailed from time to time in its publicly filed documents, including PMI's Annual Report on Form 10-K for the fourth quarter and year ended December 31, 2023, and the Quarterly Report on Form 10-Q for the second quarter ended June 30, 2024, which will be filed in the coming days. PMI cautions that the foregoing list of important factors is not a complete discussion of all potential risks and uncertainties. PMI does not undertake to update any forward-looking statement that it may make from time to time, except in the normal course of its public disclosure obligations.

    Non-GAAP Measures, Glossary and Explanatory Notes

    Reconciliations of non-GAAP measures in this release to the most directly comparable U.S. GAAP measures can be found in Exhibit 99.2 to the Form 8-K dated July 23, 2024, and at www.pmi.com/2024Q2earnings. A glossary of key terms, definitions and explanatory notes is available in the aforementioned Exhibit 99.2 and on the same webpage, where additional financial schedules, as well as adjustments and other calculations have also been made available.

    Management reviews net revenues, gross profit, operating income, operating income margin, operating cash flow and earnings per share, or "EPS," on an adjusted basis, which may exclude the impact of currency and other items such as acquisitions, asset impairment and exit costs, tax items and other special items. Additionally, starting in 2022 and on a comparative basis, for these measures other than net revenues and operating cash flow, PMI includes adjustments to add back amortization expense on acquisition related intangible assets that are recorded as part of purchase accounting and contribute to PMI's revenue generation, as well as impairment of intangible assets, if any. While amortization expense on acquisition related intangible assets is excluded in these adjusted measures, the net revenues generated from these acquired intangible assets are included in the company's adjusted measures, unless otherwise stated. Currency-neutral and organic growth rates reflect the way management views underlying performance for these measures. PMI believes that such measures provide useful insight into underlying business trends and results. Management reviews these measures because they exclude changes in currency exchange rates and other factors that may distort underlying business trends, thereby improving the comparability of PMI's business performance between reporting periods. Furthermore, PMI uses several of these measures in its management compensation program to promote internal fairness and a disciplined assessment of performance against company targets. PMI discloses these measures to enable investors to view the business through the eyes of management.

    Non-GAAP measures used in this release should neither be considered in isolation nor as a substitute for the financial measures prepared in accordance with U.S. GAAP.

    Diluted EPS reconciliation

     

     

    Second-Quarter

     

     

    2024

     

    2023

     

    % Change

    Reported Diluted EPS

     

    $

    1.54

     

     

    $

    1.01

     

     

    52.5

    %

    Impairment of goodwill and other intangibles

     

     

    —

     

     

     

    0.44

     

     

     

    Amortization of intangibles

     

     

    0.11

     

     

     

    0.04

     

     

     

    South Korea indirect tax charge

     

     

    —

     

     

     

    0.11

     

     

     

    Income tax impact associated with Swedish Match AB financing

     

     

    0.02

     

     

     

    (0.01

    )

     

     

    Fair value adjustment for equity security investments

     

     

    (0.08

    )

     

     

    0.01

     

     

     

    Adjusted Diluted EPS

     

    $

    1.59

     

     

    $

    1.60

     

     

    (0.6

    )%

    Less: Currency

     

     

    (0.18

    )

     

     

     

     

    Adjusted Diluted EPS, excluding Currency

     

    $

    1.77

     

     

    $

    1.60

     

     

    10.6

    %

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Appendix 1

    PHILIP MORRIS INTERNATIONAL INC. and Subsidiaries

    Key Market Data

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Quarters Ended June 30,

    Market

     

    Total Market,

    bio units

     

    PMI Shipments, bio units

     

    PMI Market Share(2), %

     

     

    Total

     

    Cigarette

     

    HTU

     

    Total

     

    HTU

     

    2024

    2023

    % Change

     

    2024

    2023

    % Change

     

    2024

    2023

    % Change

     

    2024

    2023

    % Change

     

    2024

    2023

    pp Change

     

    2024

    2023

    pp Change

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Total(1)(2)

     

    657.2

    647.2

    1.5

     

    193.2

    188.4

    2.5

     

    157.6

    157.0

    0.4

     

    35.5

    31.4

    13.1

     

    28.7

    28.6

    0.1

     

    5.1

    4.7

    0.4

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Europe

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    France

     

    6.7

    7.6

    (11.4)

     

    3.3

    3.7

    (11.7)

     

    3.3

    3.7

    (11.3)

     

    —

    0.1

    (37.6)

     

    41.5

    42.4

    (0.9)

     

    0.6

    0.8

    (0.2)

    Germany(3)

     

    17.3

    17.9

    (3.3)

     

    6.8

    6.9

    (0.6)

     

    5.8

    6.1

    (6.0)

     

    1.1

    0.7

    43.4

     

    39.0

    39.2

    (0.2)

     

    6.0

    5.4

    0.6

    Italy(3)

     

    18.1

    18.4

    (1.5)

     

    10.6

    9.8

    7.6

     

    8.0

    7.0

    14.5

     

    2.5

    2.8

    (9.7)

     

    53.6

    53.6

    —

     

    16.7

    17.1

    (0.4)

    Poland(3)

     

    15.0

    15.0

    0.1

     

    6.5

    6.1

    6.0

     

    5.1

    4.9

    4.4

     

    1.4

    1.2

    12.5

     

    43.3

    41.1

    2.2

     

    9.1

    8.6

    0.5

    Spain

     

    11.2

    11.3

    (0.6)

     

    3.5

    3.6

    (3.2)

     

    3.2

    3.3

    (3.7)

     

    0.3

    0.3

    2.4

     

    29.2

    29.2

    —

     

    2.6

    2.2

    0.4

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    SSEA, CIS & MEA

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Egypt

     

    19.0

    16.1

    18.6

     

    6.7

    6.0

    11.6

     

    6.3

    5.7

    11.8

     

    0.3

    0.3

    8.2

     

    34.5

    37.2

    (2.7)

     

    1.9

    1.8

    0.1

    Indonesia

     

    71.9

    72.2

    (0.5)

     

    19.6

    21.0

    (6.4)

     

    19.4

    20.8

    (7.1)

     

    0.3

    0.1

    89.1

     

    27.3

    29.1

    (1.8)

     

    0.4

    0.2

    0.2

    Philippines

     

    9.7

    10.2

    (4.8)

     

    5.1

    5.7

    (9.7)

     

    5.0

    5.6

    (10.1)

     

    0.1

    —

    —

     

    52.7

    55.6

    (2.9)

     

    0.7

    0.5

    0.2

    Russia

     

    55.1

    51.9

    6.2

     

    17.4

    16.5

    5.3

     

    12.9

    12.6

    2.6

     

    4.4

    3.9

    14.1

     

    31.6

    32.8

    (1.2)

     

    8.2

    7.9

    0.3

    Turkey

     

    38.9

    37.4

    4.1

     

    20.3

    18.5

    9.7

     

    20.3

    18.5

    9.7

     

    —

    —

    —

     

    52.3

    49.6

    2.7

     

    —

    —

    —

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    EA, AU & PMI DF

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Australia

     

    1.4

    1.9

    (29.1)

     

    0.4

    0.6

    (28.5)

     

    0.4

    0.6

    (28.5)

     

    —

    —

    —

     

    32.8

    32.5

    0.3

     

    —

    —

    —

    Japan(2)

     

    37.9

    37.6

    0.9

     

    17.5

    16.7

    5.0

     

    4.1

    4.9

    (16.7)

     

    13.4

    11.8

    14.0

     

    40.9

    39.4

    1.5

     

    29.4

    26.3

    3.1

    South Korea

     

    18.2

    18.5

    (1.9)

     

    3.6

    3.6

    (1.3)

     

    2.2

    2.3

    (6.0)

     

    1.4

    1.3

    6.9

     

    19.6

    19.5

    0.1

     

    7.7

    7.0

    0.7

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Americas

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Argentina

     

    5.9

    7.3

    (20.0)

     

    3.6

    4.5

    (19.9)

     

    3.6

    4.5

    (19.9)

     

    —

    —

    —

     

    61.5

    61.5

    —

     

    —

    —

    —

    Mexico

     

    7.4

    7.4

    0.9

     

    4.6

    4.6

    (0.4)

     

    4.6

    4.6

    (1.0)

     

    0.1

    —

    —

     

    62.2

    63.0

    (0.8)

     

    0.8

    0.4

    0.4

     

    (1) Market share estimates are calculated using IMS data, unless otherwise stated

    (2) Total market and market share estimates include cigarillos in Japan

    (3) PMI market share reflects estimated adjusted IMS volume share

    Note: % change for Total Market and PMI shipments is computed based on millions of units. "-" indicates volume below 50 million units and market share below 0.1%

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Appendix 2

    PHILIP MORRIS INTERNATIONAL INC. and Subsidiaries

    Key Market Data

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Six Months Ended June 30,

    Market

     

    Total Market,

    bio units

     

    PMI Shipments, bio units

     

    PMI Market Share(2), %

     

     

    Total

     

    Cigarette

     

    HTU

     

    Total

     

    HTU

     

    2024

    2023

    % Change

     

    2024

    2023

    % Change

     

    2024

    2023

    % Change

     

    2024

    2023

    % Change

     

    2024

    2023

    pp Change

     

    2024

    2023

    pp Change

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Total(1)(2)

     

    1,274.9

    1,261.5

    1.1

     

    369.5

    359.5

    2.8

     

    300.8

    300.7

    —

     

    68.7

    58.8

    16.8

     

    28.3

    27.9

    0.4

     

    5.1

    4.6

    0.5

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Europe

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    France

     

    13.0

    15.1

    (13.8)

     

    5.9

    7.5

    (21.7)

     

    5.8

    7.4

    (21.5)

     

    0.1

    0.1

    (33.3)

     

    40.9

    42.3

    (1.4)

     

    0.6

    0.8

    (0.2)

    Germany(3)

     

    33.3

    33.7

    (1.2)

     

    13.2

    12.9

    1.9

     

    11.1

    11.6

    (4.7)

     

    2.1

    1.3

    61.4

     

    39.4

    39.3

    0.1

     

    6.2

    5.4

    0.8

    Italy(3)

     

    35.6

    35.6

    —

     

    18.5

    18.7

    (0.9)

     

    13.7

    13.9

    (1.3)

     

    4.8

    4.8

    —

     

    53.1

    53.7

    (0.6)

     

    17.2

    17.0

    0.2

    Poland(3)

     

    29.1

    28.5

    2.3

     

    12.5

    11.6

    7.9

     

    9.9

    9.2

    7.8

     

    2.7

    2.5

    8.4

     

    43.1

    41.0

    2.1

     

    9.1

    9.0

    0.1

    Spain

     

    20.9

    21.2

    (1.1)

     

    6.3

    6.5

    (2.9)

     

    5.8

    6.0

    (4.2)

     

    0.5

    0.4

    15.7

     

    29.1

    29.1

    —

     

    2.7

    2.2

    0.5

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    SSEA, CIS & MEA

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Egypt

     

    38.4

    38.5

    (0.3)

     

    12.0

    11.7

    2.0

     

    11.3

    11.3

    0.6

     

    0.6

    0.5

    35.4

     

    30.7

    30.4

    0.3

     

    1.9

    1.4

    0.5

    Indonesia

     

    145.8

    141.4

    3.1

     

    39.4

    40.5

    (2.9)

     

    39.4

    40.5

    (2.9)

     

    0.5

    0.2

    +100

     

    27.3

    28.8

    (1.5)

     

    0.3

    0.2

    0.1

    Philippines

     

    20.0

    21.7

    (7.9)

     

    10.6

    12.3

    (14.2)

     

    10.4

    12.2

    (14.6)

     

    0.1

    0.1

    30.0

     

    52.8

    56.7

    (3.9)

     

    0.7

    0.5

    0.2

    Russia

     

    101.9

    96.7

    5.3

     

    32.9

    31.2

    5.4

     

    24.4

    23.5

    3.7

     

    8.5

    7.7

    10.5

     

    32.0

    32.0

    —

     

    8.8

    8.1

    0.7

    Turkey

     

    70.1

    63.5

    10.3

     

    36.3

    31.3

    16.0

     

    36.3

    31.3

    16.0

     

    —

    —

    —

     

    51.9

    49.3

    2.6

     

    —

    —

    —

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    EA, AU & PMI DF

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Australia

     

    2.7

    3.8

    (29.4)

     

    1.0

    1.3

    (27.2)

     

    1.0

    1.3

    (27.2)

     

    —

    —

    —

     

    35.2

    34.2

    1.0

     

    —

    —

    —

    Japan(2)

     

    73.7

    72.9

    1.0

     

    35.4

    31.5

    12.6

     

    8.4

    9.6

    (12.6)

     

    27.0

    21.9

    23.6

     

    41.0

    39.4

    1.6

     

    29.4

    26.3

    3.1

    South Korea

     

    34.7

    35.4

    (2.1)

     

    6.9

    6.9

    0.5

     

    4.2

    4.4

    (5.6)

     

    2.8

    2.5

    11.7

     

    20.0

    19.5

    0.5

     

    7.9

    6.9

    1.0

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Americas

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Argentina

     

    13.0

    15.1

    (13.8)

     

    8.0

    9.4

    (14.7)

     

    8.0

    9.4

    (14.7)

     

    —

    —

    —

     

    61.6

    62.2

    (0.6)

     

    —

    —

    —

    Mexico

     

    13.7

    13.5

    1.3

     

    8.3

    8.3

    —

     

    8.2

    8.3

    (0.6)

     

    0.1

    0.1

    78.4

     

    61.1

    61.9

    (0.8)

     

    0.8

    0.4

    0.4

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    (1) Market share estimates are calculated using IMS data, unless otherwise stated

    (2) Total market and market share estimates include cigarillos in Japan

    (3) PMI market share reflects estimated adjusted IMS volume share

    Note: % change for Total Market and PMI shipments is computed based on millions of units. "-" indicates volume below 50 million units and market share below 0.1%

     

    View source version on businesswire.com: https://www.businesswire.com/news/home/20240722676440/en/

    Get the next $PM alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $PM

    DatePrice TargetRatingAnalyst
    5/22/2025$195.00Buy
    Needham
    4/25/2025$170.00Sell → Neutral
    UBS
    3/14/2025Hold → Buy
    Argus
    1/16/2025$140.00Overweight
    Morgan Stanley
    3/5/2024Buy → Hold
    Argus
    2/13/2024Sell → Hold
    Societe Generale
    1/23/2024$105.00 → $86.50Buy → Sell
    UBS
    11/16/2023$95.00Neutral
    Redburn Atlantic
    More analyst ratings

    $PM
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Philip Morris International Holds 2025 Virtual Annual Meeting of Shareholders

      Regulatory News: Philip Morris International Inc. (PMI) (NYSE:PM) held its 2025 Annual Meeting of Shareholders today. André Calantzopoulos, Chairman of the Board, addressed shareholders and answered questions. Jacek Olczak, Chief Executive Officer, gave a business presentation, which included an overview of PMI's: excellent 2024 performance and impressive start to 2025; achievement of several key milestones in its smoke-free journey; positive results in the execution of its multicategory strategy; ability to deliver sustainable growth and returns in 2025 and beyond; steadfast commitment to shareholder returns. "Our smoke-free transformation continues to advance rapidly. We mark

      5/7/25 9:44:00 AM ET
      $PM
      Medicinal Chemicals and Botanical Products
      Health Care
    • Philip Morris International to Host Webcast of 2025 Virtual Annual Meeting of Shareholders

      Regulatory News: Philip Morris International Inc. (PMI) (NYSE:PM) will host a live audio webcast of its 2025 Annual Meeting of Shareholders on Wednesday, May 7, 2025, at 9:00 a.m. ET. The meeting will be in a virtual format and can be accessed at www.virtualshareholdermeeting.com/PM2025. Presentation slides, script and an archived recording of the webcast will be available at the same link. The recording will be available for one year from the date of the meeting. During the meeting, André Calantzopoulos, Chairman of the Board, and Jacek Olczak, Chief Executive Officer, will address shareholders and answer questions. Only shareholders of record with a valid 16-digit control number will be

      4/30/25 9:00:00 AM ET
      $PM
      Medicinal Chemicals and Botanical Products
      Health Care
    • Philip Morris International CEO Jacek Olczak Addresses Emerging Global Divide in Regulatory Approaches to Consumer Innovation

      Olczak issues call for pragmatic policies that accelerate advances in public health, noting that approximately 20% of smokers globally lack access to better alternatives to cigarettes Jacek Olczak, Chief Executive Officer of Philip Morris International Inc. (NYSE:PM), outlined the need for common-sense regulations in the consumer goods sector while addressing global leaders at Semafor's annual World Economy Summit in Washington, D.C., on April 25, 2025. Olczak emphasized the sector's potential for innovation-led growth despite the volatile economic environment. He stressed, however, that without appropriate regulation and policy frameworks to enable scientific evaluation and consumer acces

      4/28/25 8:15:00 AM ET
      $PM
      Medicinal Chemicals and Botanical Products
      Health Care

    $PM
    SEC Filings

    See more
    • SEC Form SD filed by Philip Morris International Inc

      SD - Philip Morris International Inc. (0001413329) (Filer)

      5/15/25 6:05:44 AM ET
      $PM
      Medicinal Chemicals and Botanical Products
      Health Care
    • Philip Morris International Inc filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

      8-K - Philip Morris International Inc. (0001413329) (Filer)

      5/9/25 11:35:47 AM ET
      $PM
      Medicinal Chemicals and Botanical Products
      Health Care
    • Philip Morris International Inc filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - Philip Morris International Inc. (0001413329) (Filer)

      5/7/25 9:50:34 AM ET
      $PM
      Medicinal Chemicals and Botanical Products
      Health Care

    $PM
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by Philip Morris International Inc (Amendment)

      SC 13G/A - Philip Morris International Inc. (0001413329) (Subject)

      2/9/24 6:21:26 PM ET
      $PM
      Medicinal Chemicals and Botanical Products
      Health Care
    • SEC Form SC 13G/A filed by Philip Morris International Inc (Amendment)

      SC 13G/A - Philip Morris International Inc. (0001413329) (Subject)

      2/9/24 6:05:54 PM ET
      $PM
      Medicinal Chemicals and Botanical Products
      Health Care
    • SEC Form SC 13G/A filed by Philip Morris International Inc (Amendment)

      SC 13G/A - Philip Morris International Inc. (0001413329) (Subject)

      1/29/24 3:26:29 PM ET
      $PM
      Medicinal Chemicals and Botanical Products
      Health Care

    $PM
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Temperley Dessislava was granted 1,002 shares, increasing direct ownership by 15% to 7,756 units (SEC Form 4)

      4 - Philip Morris International Inc. (0001413329) (Issuer)

      5/9/25 4:54:43 PM ET
      $PM
      Medicinal Chemicals and Botanical Products
      Health Care
    • Director Bough Bonin was granted 1,002 shares, increasing direct ownership by 11% to 9,834 units (SEC Form 4)

      4 - Philip Morris International Inc. (0001413329) (Issuer)

      5/9/25 4:54:34 PM ET
      $PM
      Medicinal Chemicals and Botanical Products
      Health Care
    • Director Harker Victoria D was granted 1,002 shares, increasing direct ownership by 41% to 3,418 units (SEC Form 4)

      4 - Philip Morris International Inc. (0001413329) (Issuer)

      5/9/25 4:54:22 PM ET
      $PM
      Medicinal Chemicals and Botanical Products
      Health Care

    $PM
    Financials

    Live finance-specific insights

    See more

    $PM
    Leadership Updates

    Live Leadership Updates

    See more
    • Philip Morris International Reports First-Quarter 2025 Results and Raises 2025 Full-Year Adjusted Diluted EPS Forecast for Currency Only

      Reported Diluted EPS Grew 24.6% to $1.72 Adjusted Diluted EPS Grew 12.7% to $1.69; and by 17.3% excluding currency Regulatory News: Philip Morris International Inc. (PMI) (NYSE:PM) today announces its 2025 first-quarter results.1 "We achieved exceptionally strong performance in the first quarter, with continued volume growth supporting an excellent top-line performance and very strong margin expansion," said Jacek Olczak, Chief Executive Officer. "Our smoke-free business goes from strength to strength, delivering organic growth of over 20% in net revenues and over 33% in gross profit." "We remain confident in our ability to deliver superior results, despite an uncertain and volatile glob

      4/23/25 6:59:00 AM ET
      $PM
      Medicinal Chemicals and Botanical Products
      Health Care
    • Court Approves CCAA Plans to Resolve Tobacco Product-Related Claims and Litigation in Canada

      Regulatory News: Philip Morris International Inc. (PMI) has been informed by its deconsolidated Canadian affiliate, Rothmans, Benson & Hedges Inc. (RBH), that the court in RBH's Companies' Creditors Arrangement Act (CCAA) proceeding has approved a plan of compromise and arrangement for RBH (the Plan). The Plan, as approved, will resolve all tobacco product-related claims and litigation in Canada against RBH and its affiliates, including PMI. The court also approved substantially similar plans for Imperial Tobacco Canada Limited and Imperial Tobacco Company Limited (together, ITL) and JTI-Macdonald Corp. (JTIM). As previously disclosed, RBH's court-appointed mediator and monitor filed a pr

      3/7/25 8:00:00 AM ET
      $PM
      Medicinal Chemicals and Botanical Products
      Health Care
    • Philip Morris International Declares Regular Quarterly Dividend of $1.35 Per Share

      Regulatory News: The Board of Directors of Philip Morris International Inc. (NYSE:PM) today declared a regular quarterly dividend of $1.35 per common share, payable on April 10, 2025, to shareholders of record as of March 20, 2025. The ex-dividend date is March 20, 2025. For more details on stock, dividends and other information, see www.pmi.com/dividend. Philip Morris International: Delivering a Smoke-Free Future Philip Morris International is a leading international tobacco company, actively delivering a smoke-free future and evolving its portfolio for the long term to include products outside of the tobacco and nicotine sector. The company's current product portfolio primarily consist

      3/6/25 10:44:00 AM ET
      $PM
      Medicinal Chemicals and Botanical Products
      Health Care
    • Molex, a Parent to Phillips Medisize, Announces Agreement to Acquire the Vectura Group Limited, Expanding Its Drug Delivery Capabilities in Inhalation

      Pharmaceutical customers and patients to benefit from the combined design, development and manufacturing services of Vectura and Phillips Medisize Phillips Medisize to add a market-leading position in inhalation combination product development to its existing suite of drug delivery device design capabilities Vectura employees to join a large global company, dedicated to improving patients' lives through innovative products and world class quality and manufacturing capabilities Molex, a parent to Phillips Medisize, a leader in the design, engineering and manufacturing of pharmaceutical drug delivery, in vitro diagnostic and medtech devices, announced that, through its affiliate Molex

      9/17/24 9:11:00 AM ET
      $PM
      Medicinal Chemicals and Botanical Products
      Health Care
    • Philip Morris International Names New External Affairs Leader

      Philip Morris International Inc. (PMI) (NYSE:PM) is pleased to announce the appointment of Christos Harpantidis to the position of Senior Vice President, External Affairs effective May 1, 2024. In his new role, Mr. Harpantidis will report to the company's CEO, Jacek Olczak. "Christos is an experienced business leader with a proven track record of engaging society on the benefits of tobacco harm reduction and risk-proportionate regulation for smoke-free products," said CEO Jacek Olczak. "He has been instrumental in building our smoke-free business in Greece and the South East Europe Area as we evolve away from cigarettes. I'm looking forward to working with Christos and excited to see what

      3/26/24 5:48:00 AM ET
      $PM
      Medicinal Chemicals and Botanical Products
      Health Care
    • Philip Morris International's U.S. Business Champions Female Economic Growth in Connecticut with Record-Setting $5 Million Investment Through New Partnership with Women's Business Development Council

      In honor of Women's History Month and in advance of International Women's Day, investment and partnership support female economic empowerment and equality through entrepreneurship Today, Philip Morris International (PMI) (NYSE:PM) announces the launch of an extended partnership via its U.S. business to support female empowerment with a record-setting $5 million investment in the Women's Business Development Council (WBDC), a 501(c)(3) charitable organization dedicated to providing tools and resources to help women entrepreneurs thrive in business throughout Connecticut. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/202403048002

      3/4/24 6:48:00 PM ET
      $PM
      Medicinal Chemicals and Botanical Products
      Health Care

    $PM
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Needham initiated coverage on Philip Morris International with a new price target

      Needham initiated coverage of Philip Morris International with a rating of Buy and set a new price target of $195.00

      5/22/25 8:27:06 AM ET
      $PM
      Medicinal Chemicals and Botanical Products
      Health Care
    • Philip Morris International upgraded by UBS with a new price target

      UBS upgraded Philip Morris International from Sell to Neutral and set a new price target of $170.00

      4/25/25 8:25:28 AM ET
      $PM
      Medicinal Chemicals and Botanical Products
      Health Care
    • Philip Morris International upgraded by Argus

      Argus upgraded Philip Morris International from Hold to Buy

      3/14/25 7:44:58 AM ET
      $PM
      Medicinal Chemicals and Botanical Products
      Health Care